Skip to main content
. 2017 Sep 23;8(52):89978–89987. doi: 10.18632/oncotarget.21208

Table 2. Baseline characteristics of CTC-negative and CTC-positive patients.

Patients
CTC-negative, n=48 (%) CTC-positive, n=9 (%) P-value
Gender (%)
Male
Female
36 (75.0)
12 (25.0)
8 (88.9)
1 (11.1)
0.362
Age (years)
Mean ± SD
64.2 ± 12.0 61.4 ± 4.2 0.528
Liver cirrhosis (%)
Yes
No
18 (37.5)
30 (62.5)
6 (66.7)
3 (33.3)
0.104
Child-Pugh classification (%)
A
B
13 (75.0)
5 (25.0)
5 (83.3)
1 (16.7)
0.950
Etiology of liver disease
Alcohol#
Chronic viral hepatitis#
NASH
Venous occlusive disease
PBC with secondary AIH
Cryptogenic cirrhosis
None
6
12
10
2
1
2
16
1
9
0
0
0
0
0
0.006
BCLC staging*
A
B
17
1
5
1
0.446
Tumor Grading (G)§
1
2
3
13
32
2
2
6
1
0.403
Tumor size (T)§
1
2
3
23
13
1
3
5
1
0.410
Vascular Invasion (V)§
0
1
2
30
16
1
5
4
0
0.639
Resection margin (R)§
0
1
41
6
8
1
0.891
Recurrence
N (%)
RFS in months
28 (58)
12.0 ± 2.5
8 (89)
5.0 ± 1.5
0.027

Abbreviations: SD, standard deviation; NASH, non-alcoholic steatohepatitis; PBC, primary biliary cholangitis; AIH, autoimmune hepatitis; T, tumor size; V, vascular invasion; R, resection margin. #Two patients revealed multiple risk factors. *Only applicable for cirrhotic patients. §In one patient histopathological analysis was not possible due to complete necrosis after prior treatment.